clindamycin

Generic: clindamycin phosphate

Labeler: sagent pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clindamycin
Generic Name clindamycin phosphate
Labeler sagent pharmaceuticals
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

clindamycin phosphate 150 mg/mL

Manufacturer
Sagent Pharmaceuticals

Identifiers & Regulatory

Product NDC 25021-115
Product ID 25021-115_4662502b-ce7c-4278-854d-cf8632ac9b83
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090108
Listing Expiration 2026-12-31
Marketing Start 2012-05-15

Pharmacologic Class

Classes
decreased sebaceous gland activity [pe] lincosamide antibacterial [epc] lincosamides [cs] neuromuscular blockade [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 25021115
Hyphenated Format 25021-115

Supplemental Identifiers

RxCUI
1737244 1737578 1737581
UNII
EH6D7113I8

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clindamycin (source: ndc)
Generic Name clindamycin phosphate (source: ndc)
Application Number ANDA090108 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 150 mg/mL
source: ndc
Packaging
  • 25 VIAL in 1 CARTON (25021-115-02) / 2 mL in 1 VIAL
  • 25 VIAL in 1 CARTON (25021-115-04) / 4 mL in 1 VIAL
  • 25 VIAL in 1 CARTON (25021-115-06) / 6 mL in 1 VIAL
source: ndc

Packages (3)

25021-115-02 25 VIAL in 1 CARTON (25021-115-02) / 2 mL in 1 VIAL 25021-115-04 25 VIAL in 1 CARTON (25021-115-04) / 4 mL in 1 VIAL 25021-115-06 25 VIAL in 1 CARTON (25021-115-06) / 6 mL in 1 VIAL

Ingredients (1)

clindamycin phosphate (150 mg/mL)

Linked Drug Pages (1)

Clindamycin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "4662502b-ce7c-4278-854d-cf8632ac9b83", "openfda": {"unii": ["EH6D7113I8"], "rxcui": ["1737244", "1737578", "1737581"], "spl_set_id": ["7a6967b3-5563-4bed-9eee-d400f800e799"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (25021-115-02)  / 2 mL in 1 VIAL", "package_ndc": "25021-115-02", "marketing_start_date": "20120515"}, {"sample": false, "description": "25 VIAL in 1 CARTON (25021-115-04)  / 4 mL in 1 VIAL", "package_ndc": "25021-115-04", "marketing_start_date": "20120515"}, {"sample": false, "description": "25 VIAL in 1 CARTON (25021-115-06)  / 6 mL in 1 VIAL", "package_ndc": "25021-115-06", "marketing_start_date": "20120515"}], "brand_name": "Clindamycin", "product_id": "25021-115_4662502b-ce7c-4278-854d-cf8632ac9b83", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Lincosamide Antibacterial [EPC]", "Lincosamides [CS]", "Neuromuscular Blockade [PE]"], "product_ndc": "25021-115", "generic_name": "Clindamycin Phosphate", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clindamycin", "active_ingredients": [{"name": "CLINDAMYCIN PHOSPHATE", "strength": "150 mg/mL"}], "application_number": "ANDA090108", "marketing_category": "ANDA", "marketing_start_date": "20120515", "listing_expiration_date": "20261231"}